A transplant recipient with a mixed germ-cell ovarian tumor.
Immunosuppressed renal transplant recipients seem to be at significantly increased risk of developing neoplasms comparatively to nonimmunosuppressed individuals. A history of malignancy exposes the patient to a high risk for relapse after transplantation. We present a trans-plant recipient with a history of an ovarian mixed germ-cell tumor, with choriocarcinoma component, which was treated seven years prior to transplantation. After three years of follow-up, there was no evidence of tumor relapse. To our knowledge, there is no report of such case in the English literature. Regarding our case report and patients with a history of ovarian germ-cell neoplasm, waiting time before transplantation must take into consideration the stage of the tumor, its prognosis, the proportion of different tumor components, and the overall prognosis of the patient if transplantation is withheld.
Ketata
Hafed
H
Department of Urology, CHU Habib Bourguiba, Sfax, Tunisia. khafed@yahoo.fr
Bouacida
Mahdi
M
Bouhlel
Abdelkader
A
Sahnoun
Ahmed
A
Bahloul
Ali
A
Yaich
Soumaya
S
Hachicha
Jamil
J
Mhiri
Mohamed Nabil
MN
D015897:Comorbidity; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000601:surgery; D016030:Kidney Transplantation; D009373:Neoplasms, Germ Cell and Embryonal / Q000453:epidemiology*; D010051:Ovarian Neoplasms / Q000453:epidemiology*; D011379:Prognosis; D055815:Young Adult